Two presentations for our novel MIGS device, MINIject®, were delivered at the 125th American Academy of Ophthalmology (AAO 2021) meeting in New Orleans, Louisiana.
Interim results at 3 years from the STAR-GLOBAL trial were presented by Dr Steven Vold, and final 2 year results for the STAR-II European trial were presented by Dr I. Paul Singh.
Both presentations will be available as on-demand posters throughout the AAO meeting.
